image
Healthcare - Biotechnology - NASDAQ - CA
$ 1.75
-0.575 %
$ 80.1 M
Market Cap
-1.41
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
20.36%
EBIT Estimate
--26.04%
Net Income Estimate
22.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets ImmunoPrecise Antibodies Ltd.
image
IPA has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart IPA

image
$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0201920192020202020212021202220222023202320232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart IPA

image
$5.0m$5.0m$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)201920192020202020212021202220222023202320232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart IPA

image
$10.0m$10.0m$5.0m$5.0m$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)201920192020202020212021202220222023202320232023202420242025202520262026202720272028202820292029